BiotechTube
JSC Valenta Pharmaceuticals

JSC Valenta Pharmaceuticals

Moscow, Europe - Other· Est.
valentapharm.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Valenta Pharm is a prominent, privately-held Russian pharmaceutical company with a 29-year history, operating in the small molecules sector. It has established a commercial portfolio across several therapeutic areas, including CNS, gastroenterology, and cough/cold, and engages in R&D for novel drugs. The company leverages its substantial manufacturing capabilities in Russia and has gained some international scientific recognition for its research, though its operational and market focus remains heavily domestic.

Neuropsychiatry (CNS)GastroenterologyCough & ColdImmunology/VirologyWomen's Health

Technology Platform

Focus on small molecule drug development and large-scale, high-tech pharmaceutical manufacturing.

Opportunities

Benefiting from Russian import substitution policies to increase domestic market share.
Strong demand in core therapeutic areas like CNS and gastroenterology provides a stable revenue base.
Ownership of large-scale manufacturing offers cost control and supply chain security.

Risk Factors

High exposure to Russian macroeconomic and geopolitical risks, including sanctions and supply chain disruption.
Scientific and commercial isolation from Western markets limits innovation and global growth.
Subject to stringent government price controls in its primary market.

Competitive Landscape

Competes as a domestic innovator against other Russian pharma companies and generic manufacturers within a market increasingly shielded from Western multinationals. Faces potential long-term competition from other non-Western producers (e.g., China, India) in the CIS region.

More companies in Europe - Other →